Latest Breaking News On - Xilin wu - Page 1 : comparemela.com

Nanobodies protect against SARS-CoV-2 variants in animal model As of today, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 108 million individuals and claimed the lives of nearly 2.7 million globally. This past year management of the COVID-19 pandemic solely relied on non-pharmaceutical interventions such as school closures, physical distancing, shielding of those at heightened risk, and self-isolation of symptomatic cases. Currently, prophylactic vaccines - developed at an unprecedented pace are being administered across the globe. However, many viral variants are emerging, threatening the success of the on-going efforts. Despite the adopted mitigation strategies, the COVID-19 pandemic requires multiple countermeasures.

United kingdomSouth africaXilin wuLin chengRamya dwivediMing fuAnimal modelSars cov 2Corona virusCoronavirus disease covid 19In vitroIn vivoSevere acute respiratorySevere acute respiratory syndromeSpike proteinஒன்றுபட்டது கிஂக்டம்